Japanese healthcare startup Bisu raises $3.2M seed round to launch its lab-on-a-chip product – TechCrunch

Telemedicine service adoption has grown rapidly in a pandemic — usage has increased 38-fold since January 2020. Report by McKinsey..While much attention is being paid to companies that are building a layer of communication between consumers and clinicians, there is also a wave of companies that are building. device To extend what can be monitored and addressed in a telemedicine environment.

In one of the latest developments Screw — — A Tokyo-based healthcare start-up has built a lab-grade test device that can be used at home for diagnostics that translates into actionable health data. Raised $ 3.2 million. The seed round will be used to launch the Bisu Body Coach, a portable home medical lab. The lab provides personalized nutrition and lifestyle advice through simple and accurate urine and saliva tests. With seed funding, the total amount will be $ 4.3 million.

The latest funding QuadWith participation from ASICS Ventures Corporation, 15th Rock Ventures, Pacifico Investments, SOSV. Athletic shoe giant ASICS is a strategic backer and will work with Bis on a health and fitness services initiative. Bisu is discussing additional partnerships with other companies in the areas of fitness, pet care and bathrooms, co-founder and CEO Daniel Maggs told TechCrunch.

Bis was founded in 2015 and started operations in 2017. HAX Accelerator Program..

Bisu Body Coach avoids disposable test sticks and readers that sync with smartphone applications. Disposable test sticks allow users to measure a variety of biomarkers in just two minutes using microfluidic “lab-on-a-chip” technology.

Microfluidic “lab-on-a-chip” technology uses spectroscopic analysis and real-time end-to-end measurements to eliminate measurement timing issues on traditional test strips. It also manipulates samples of blood, urine, saliva, sweat, etc. within a small channel to perform chemical or biological processes.

When asked about differentiating themselves from other competitors using lab-on-a-chip technology, Bisu enables users to understand their diet and lifestyle and make positive changes without seeing a doctor. He said he is focusing on simultaneous testing of multiple biomarkers. Others can usually detect high-value individual biomarkers, such as COVID-19 and the flu, and lead users to seek help from their doctor.

The Bisu app provides feedback on key nutritional indicators such as hydration, minerals, vitamins, pH, uric acid and ketones. Bisu Body Coach provides personalized recommendations based on your goals, preferences, activities, sleep and weight. Bisu plans to add zinc and B vitamin measurements in the future and will release a pet health check kit for cats and dogs.

Bisu Body Coach is currently in beta testing in the United States and the European Union. The company is aiming to commercialize in these markets in 2022, Magus said, adding that it is laying the foundation for entering Asian markets such as Japan and South Korea in 2023.

Its core R & D and production team is based in Tokyo, and Bisu’s software and marketing team is based in the United States.

Maggs is a traditional home diagnostics market that is primarily patient-dominated. Growing to about $ 5 billion..

However, Bis home testing also has potential markets for non-patients, those who do not care for doctors or others but want to know more about what is happening in the body. .. According to Maggs, the market for non-patient home diagnostics is currently estimated at about $ 10 billion.

Japanese healthcare startup Bisu raises $3.2M seed round to launch its lab-on-a-chip product – TechCrunch Source link Japanese healthcare startup Bisu raises $3.2M seed round to launch its lab-on-a-chip product – TechCrunch

Related Articles

Back to top button